Juvenile idiopathic arthritis, childhood-onset systemic lupus erythematosus, childhood-onset Sjogren syndrome
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The patients with the target diseases
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The development of guidelines and establishment of the disease registration system | — |
Countries
Japan
Contacts
Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University Department of Pharmacovigilance